Thrombosis in Behçet’s disease: a Behçet’s disease patient with complete thrombotic obstruction of IVC and both iliac veins and decreased protein S activity

2011 ◽  
Vol 33 (6) ◽  
pp. 1633-1635 ◽  
Author(s):  
Harin Jeong ◽  
In-kyung Yoo ◽  
Sungjae Choi ◽  
Youngho Lee ◽  
Jongdae Ji ◽  
...  
2006 ◽  
Vol 27 (1) ◽  
pp. 39-43 ◽  
Author(s):  
Seong Ryul Kwon ◽  
Mie Jin Lim ◽  
Shin Goo Park ◽  
Yeon Sook Moon ◽  
Won Park

1998 ◽  
Vol 37 (2) ◽  
pp. 124-125 ◽  
Author(s):  
Nurdan Lenk, MD ◽  
Gülsüm Özet, MD ◽  
Nuran Alli, MD ◽  
Özgül Çoban, MD ◽  
Servet Erbaşi, MD

2021 ◽  
Author(s):  
Xin Yao ◽  
Xin-Ning Wang ◽  
Zhi-Xuan Zhou ◽  
Sheng-Nan Li ◽  
Jianming Lai

Abstract Background To explore the clinical characteristics, treatment regimen, and prognosis of cardiac valvular involvement in pediatric Behcet's disease. Methods Retrospective analysis was conducted on the clinical data obtained from one pediatric patient suffering from Behcet's disease with cardiac valvular involvement. Present study also reviewed the literature related to cardiac involvement in pediatric Behcet's disease. Results The disease onset in the female patient was reported at the age of 3 years, with clinical symptoms, including apthous ulcers, fever, perianal ulcers, and erythema nodosum, accompanied by a significant increase in the inflammatory markers. Echocardiography indicated that aortic valve (AV) lesions, which were absent initially, developed later, gradually exacerbated. Initially, she was diagnosed as "infectious disease" and "systemic inflammatory response syndrome", and antibiotic therapy proved ineffective. After an accurate diagnosis of Behcet's disease, the patient was given glucocorticoids, immunosuppressants, and biologics, which resulted in the relief of the symptoms; however, cardiac valvular lesions continued to exacerbate. Subsequent treatment included medical treatment and surgical treatment, and the patient's condition was stable at follow-up. Conclusions Cardiac valvular lesions in pediatric Behcet's disease are rare with insidious onset, enhancing the propensity of misdiagnosis or missed diagnosis. Main manifestations include recurrent oral ulceration, skin lesions, and fever. Cardiac involvement may occur early, yet the symptoms are insidious, requiring comprehensive physical examination and close monitoring of echocardiography. Glucocorticoids combined with immunosuppressants are the primary therapy for cardiac involvement in Behcet's disease. When cardiac valvular damage and dysfunction are observed, treatment regimens can be jointly recommended by multidisciplinary consultation to conduct the surgical treatment on time.


Author(s):  
Hanane Ezzouine ◽  
Mehdi Simou ◽  
Aymane El Louadghiri ◽  
Mounir Louardi ◽  
Imane Khaoury ◽  
...  

A new family type of coronavirus (SARS-CoV-2) was first seen in Wuhan, China name coronavirus disease 2019 (COVID-19). COVID-19 primarily attacks the respiratory system, but several studies have shown that infection with SARS-COV-2 can cause thrombosis and have therefore considered COVID-19 to be a prothrombotic disease. Behçet's disease (MB) is a systemic vasculitis. Its ethiopathogeny is still poorly understood. Blood vessels of any caliber can be affected. Arterial involvement, such as thrombosis and / or aneurysm, is possible. This article reports the case of SARS-COV-2 infection in a patient with behcet's disease.


1998 ◽  
Vol 26 (4) ◽  
pp. 206-208 ◽  
Author(s):  
M Nalçaci ◽  
Y Pekçelen

The association between natural inhibitors of coagulation and thrombophilia was investigated in 35 patients with Behçet's disease. Antithrombin III and protein C levels were measured using synthetic chromogenic substrate methods, and protein S levels by quantitative enzyme-linked immunosorbent assay. There were no significant differences between patients and controls in plasma antithrombin III, protein C and free protein S concentrations. We conclude that there was no evidence of a primary coagulation inhibitor abnormality in patients with Behçet's disease.


Cureus ◽  
2021 ◽  
Author(s):  
Amal O Al-Balbeesi ◽  
Rama A Alhallaf ◽  
Najlaa A Alsubeeh ◽  
Amany A Fathaddin ◽  
Asma A Bedaiwi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document